Symptoms And Treatment Of The Chronic Obstructive Pulmonary Disease

1074 Words Oct 2nd, 2016 5 Pages
Beneficial effects of the beta adrenergic antagonists in the treatment of the chronic obstructive pulmonary disease.

It is not uncommon for the patients to present with two or more disease states at the same time. Thus, the management of such concomitant disease states may be pharmacologically challenging as it is, for example, in the treatment of the chronic obstructive pulmonary disease (COPD) and hypertension (HTN) with a compelling indication of the post-myocardial infarction (post-MI). COPD is a progressive respiratory condition characterized by the inadequate airflow which makes the breathing more difficult. COPD patients are commonly treated with the bronchodilators such as the beta-2 adrenergic agonists.1 The beta-2 agonists stimulate the beta-2 adrenergic receptors which are found primarily in the lungs and peripheral vasculature. The stimulation of these receptors elicits airway dilation and aids the breathing process. Hypertension (HTN) is the major risk factor for developing a cardiovascular disease (CVD) which can lead to other complications such as myocardial infarction (MI). The mainstay of the pharmacological therapy in the post-MI patients with HTN is the treatment with the beta blockers (BB).2 The BB can be categorized as either non-selective or cardioselective. The non-selective BB block both the beta-1 and the beta-2 receptors. The cardioselective BB are more specific for the beta-1 receptors which can be found in the heart. Although, even the…

Related Documents